Abstracts tagged "obesity and psoriatic arthritis"

Abstract Number: 2768 • 2016 ACR/ARHP Annual Meeting
Prevalence of Obesity in Patients with Psoriatic Arthritis and Its Impact on the Severity of the Disease
Cecilia Zaffarana¹, Josefina Gallino Yanzi², Osvaldo Luis Cerda³, Margarita Landi⁴, Emilce Schneeberger¹ and Gustavo Citera¹, ¹Rheumatology Section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ²Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ³IREP, CABA, Argentina, ⁴Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina
Background/Purpose: Epidemiological studies have found a high prevalence of obesity in patients with Psoriatic Arthritis (PsA). It was described the association between obesity and severity…
Abstract Number: 1480 • 2015 ACR/ARHP Annual Meeting
Adiposity in Children with Juvenile Psoriatic Arthritis (JPsA)
Aaida Samad¹, Matthew L. Stoll², Idit Lavi³, Kriti Gupta¹, Joyce Hsu⁴, Vibeke Strand^5,6, Elizabeth D. Mellins⁷, Devy Zisman⁸ and for the CARRA Registry Investigators, ¹Dept of Pediatrics CSSR, Stanford University Med Ctr, Stanford, CA, ²University of Alabama at Birmingham, Birmingham, AL, ³Department of Community Medicine and Epidemiology, Carmel Medical Center, Haifa, Israel, ⁴Pediatric Rheumatology, Stanford University, Palo Alto, CA, ⁵Stanford University, Palo Alto, CA, ⁶Biopharmaceutical Consultant, Portola Valley, CA, ⁷Dept of Pediatrics CCSR, Stanford University Med Ctr, Stanford, CA, ⁸Rheumatology Unit, Carmel Medical CenterThe Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel, Haifa, Israel
Background/Purpose: To assess the adiposity/BMI of children diagnosed with JPsA in a North American registry, examining differences between overweight and non-overweight patients with regard to…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].